Clinical Trial Update: Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing ovulation induction in Polycystic Ovary Syndrome using a combination of myoinositol, L-arginine, chromium, and letrozole. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Chromium (Chromium)
• L-Arginine (L-Arginine)
• Letrozole (letrozole)
• Myoinositol (myo-inositol)

Snippet

Sponsor: Beni-Suef University | Conditions: Polycystic Ovary Syndrome | Phase 3 | Status: NOT_YET_RECRUITING